Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J. Gibson, Benjamin L. Ebert, R. Coleman Lindsley et al.|Journal of Clinical Oncology|2017Cited by 468
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Tao Wang et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with <i> <scp>FLT</scp> 3 </i> ‐ <scp>ITD</scp> acute myeloid leukaemia in first complete remissionAndrew M. Brunner, Yi‐Bin Chen, Shuli Li et al.|British Journal of Haematology|2016Cited by 174
Cord-Blood Hematopoietic Stem Cell Transplant Confers an Increased Risk for Human Herpesvirus-6-Associated Acute Limbic Encephalitis: A Cohort AnalysisJoshua A. Hill, Francisco M. Marty, Sophia Koo et al.|Biology of Blood and Marrow Transplantation|2012Cited by 162